# Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis

> **NCT04535349** · NA · RECRUITING · sponsor: **University Hospital, Caen** · enrollment: 35 (estimated)

## Conditions studied

- Amyloidosis Transthyretin

## Interventions

- **DIAGNOSTIC_TEST:** Whole-body & CZT bone tracer imaging (SPECT)

## Key facts

- **NCT ID:** NCT04535349
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-08
- **Primary completion:** 2025-06-15
- **Final completion:** 2025-06-15
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04535349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04535349, "Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04535349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
